The Trump administration this week decimated HIV prevention programs across government health agencies after terminating ...

A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...

Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...

CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier ...

IHL-42X is designed to treat OSA by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing through the RePOSA Phase ...

IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial with the addition of Butler Hospital’s Memory and Aging ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

Gene therapy for cystic fibrosis is advancing fast. Explore key biotech players, clinical progress, and its potential to ...

University of Kentucky Markey Cancer Center researchers presented promising results from an early-stage clinical trial ...

Cambridge Cognition (AIM: COG), the brain health software group specialising in digital products to advance clinical research and patient treatment, has been selected by a major pharmaceutical company ...

Keymed Biosciences Inc. (HKEX: 02162) ('Keymed' or the 'Company') today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its ...

Demolition works as part of preparations for the second phase of the Liverpool Health and Academic Precinct (LHAP) redevelopment of Liverpool Hospital will begin this month.